CH25H
CH25H (cholesterol 25-hydroxylase) is an endoplasmic reticulum membrane enzyme that converts cholesterol into 25-hydroxycholesterol. This oxysterol links lipid metabolism to lymphoid cell positioning, antiviral defence and the control of inflammation. Browse Assay Genie's current range of CH25H research reagents below, or read on for the biology behind the target.
CH25H catalyses the formation of 25-hydroxycholesterol from cholesterol. This product represses cholesterol biosynthetic enzymes, and CH25H may help regulate lipid metabolism by generating a corepressor that blocks sterol regulatory element binding protein (SREBP) processing. 25-hydroxycholesterol is also an intermediate in the synthesis of 7-alpha,25-dihydroxycholesterol, an oxysterol that acts as a ligand for the G protein-coupled receptor GPR183/EBI2. That receptor is chemotactic for a number of lymphoid cells, so CH25H plays a key role in cell positioning and movement in lymphoid tissues.
The CH25H gene is intronless, and the encoded protein is a membrane protein with clusters of histidine residues that are essential for catalytic activity. It belongs to the sterol desaturase family and sits in the HGNC group of fatty acid hydroxylase domain containing proteins. Unlike most other sterol hydroxylases, it is a member of a small family of enzymes that use diiron cofactors to hydroxylate hydrophobic substrates. Mouse and rat both carry a Ch25h ortholog.
CH25H is an interferon-stimulated gene with broad antiviral activity against a wide range of enveloped viruses, including vesicular stomatitis virus and SARS-CoV-2. Its product, 25-hydroxycholesterol, activates the ER-localised enzyme ACAT to induce internalisation of accessible cholesterol from the plasma membrane. It also restricts SARS-CoV-2 S protein-mediated fusion, which inhibits virus replication. In macrophages, CH25H is required to restrain inflammation: 25-hydroxycholesterol protects against cholesterol overload, which prevents mitochondrial DNA release and activation of the AIM2 inflammasome. In testis, macrophage production of 25-hydroxycholesterol contributes to Leydig cell differentiation.
CH25H is an interferon-stimulated gene whose product, 25-hydroxycholesterol, restricts enveloped viruses such as VSV and SARS-CoV-2.
25-hydroxycholesterol represses cholesterol biosynthetic enzymes and may block SREBP processing, making CH25H relevant to sterol homeostasis.
CH25H supports synthesis of an oxysterol ligand for GPR183/EBI2, which guides the positioning and movement of lymphoid cells.
CH25H-derived 25-hydroxycholesterol limits cholesterol overload in macrophages, preventing mitochondrial DNA release and AIM2 inflammasome activation.
CH25H catalyses the formation of 25-hydroxycholesterol from cholesterol. This oxysterol represses cholesterol biosynthetic enzymes, feeds into the synthesis of a GPR183/EBI2 ligand for lymphoid cell movement, and contributes to antiviral defence and restraint of macrophage inflammation.
CH25H belongs to the sterol desaturase family and to the HGNC group of fatty acid hydroxylase domain containing proteins. Unlike most sterol hydroxylases, it uses a diiron cofactor, and histidine clusters in the protein are essential for its catalytic activity.
Mouse and rat both have a Ch25h ortholog. CH25H is an interferon-stimulated gene with broad antiviral activity against enveloped viruses, including VSV and SARS-CoV-2, so check the datasheet of any product for its validated reactivity.
Other CH-prefixed enzymes and metabolic proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O95992; product specifications from Assay Genie datasheets.